Algo version: 0.98b
ChengDu ShengNuo Biotec is listed at the SHH Exchange
ChengDu ShengNuo Biotec [688117.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers - Specialty & Generic

Is ChengDu ShengNuo Biotec stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, ChengDu ShengNuo Biotec pays dividends. Last time was Friday 14th of June 2024 where the investors holding the stock on Friday 14th of June 2024 were paid CNY0.2 per share. Over the last 3 times between 2022 and 2024, ChengDu ShengNuo Biotec has paid CNY0.85 with an average of CNY0.28 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for ChengDu ShengNuo Biotec 10 years ago, but if you had invested on Thursday 3rd of June 2021 when the price was CNY46.79, you would have made a loss of CNY-18.41 per share or -39.35%

Yes, the average daily trading liquidity for ChengDu ShengNuo Biotec is CNY3.34 million. You should therefore be able to get in and out of your positions relatively fast.

ChengDu ShengNuo Biotec has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. ChengDu ShengNuo Biotec has a good net profit margin of 15.78% and should have high tolerances against inflation.

We have calculated the inflation risk for ChengDu ShengNuo Biotec to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.